Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:58 pm Purchase | 13G | DIANTHUS THERAPEUTICS INC DNTH | CITADEL ADVISORS LLC | 2,880 0% | 2,880 (New Position) | View |
| 2024-02-14 4:58 pm Sale | 13G | FIGS INC FIGS | CITADEL ADVISORS LLC | 611,989 0.4% | -8,605,659 (-93.36%) | View |
| 2024-02-14 4:58 pm Purchase | 13G | ALTI GLOBAL INC ALTI | CITADEL ADVISORS LLC | 441 0% | 441 (New Position) | View |
| 2024-02-14 4:58 pm Purchase | 13G | INFLECTION PT ACQUISITION CORP IPXX | CITADEL ADVISORS LLC | 3,666 0% | 3,666 (New Position) | View |
| 2024-02-14 4:58 pm Purchase | 13G | ALCHEMY INVTS ACQUISITION CORP ALCY | CITADEL ADVISORS LLC | 1,985 0% | 1,985 (New Position) | View |
| 2024-02-14 4:58 pm Sale | 13G | 2SEVENTY BIO INC TSVT | CITADEL ADVISORS LLC | 146,401 0.3% | -2,445,205 (-94.35%) | View |
| 2024-02-14 4:58 pm Sale | 13G | ARHAUS INC ARHS | CITADEL ADVISORS LLC | 450,504 0.9% | -2,437,203 (-84.40%) | View |
| 2024-02-14 4:58 pm Sale | 13G | PMV PHARMACEUTICALS INC PMVP | CITADEL ADVISORS LLC | 1,236,850 2.4% | -1,022,891 (-45.27%) | View |
| 2024-02-14 4:58 pm Sale | 13G | SEMPER PARATUS ACQUISITION COR LGST | CITADEL ADVISORS LLC | 5,846 0% | -927,608 (-99.37%) | View |
| 2024-02-14 4:58 pm Purchase | 13G | ENLIVEN THERAPEUTICS INC ELVN | CITADEL ADVISORS LLC | 2,394,448 5.8% | 95,692 (+4.16%) | View |
| 2024-02-14 4:58 pm Sale | 13G | ANNEXON INC ANNX | CITADEL ADVISORS LLC | 1,069,087 1.4% | -1,431,220 (-57.24%) | View |
| 2024-02-14 4:58 pm Sale | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | CITADEL ADVISORS LLC | 390,512 0.7% | -2,292,302 (-85.44%) | View |
| 2024-02-14 4:58 pm Sale | 13G | DESIGN THERAPEUTICS INC DSGN | CITADEL ADVISORS LLC | 1,834,854 3.3% | -1,036,413 (-36.10%) | View |
| 2024-02-14 4:58 pm Sale | 13G | WESTERN ALLIANCE BANCORPORATIO WAL | CITADEL ADVISORS LLC | 2,705,253 2.5% | -3,230,285 (-54.42%) | View |
| 2024-02-14 4:58 pm Sale | 13G | ALLAKOS INC ALLK | CITADEL ADVISORS LLC | 3,304,622 3.8% | -1,462,307 (-30.68%) | View |
| 2024-02-14 4:58 pm Sale | 13G | ICOSAVAX INC ICVX | CITADEL ADVISORS LLC | 283,079 0.6% | -1,906,390 (-87.07%) | View |
| 2024-02-14 4:58 pm Sale | 13G | COHERUS BIOSCIENCES INC CHRS | CITADEL ADVISORS LLC | 2,047,286 1.8% | -3,767,788 (-64.79%) | View |
| 2024-02-14 4:58 pm Purchase | 13G | JANUX THERAPEUTICS INC JANX | CITADEL ADVISORS LLC | 3,125,897 6.8% | 999,762 (+47.02%) | View |
| 2024-02-14 4:58 pm Sale | 13G | NEKTAR THERAPEUTICS NKTR | CITADEL ADVISORS LLC | 5,635,132 3% | -4,094,620 (-42.08%) | View |
| 2024-02-14 4:58 pm Purchase | 13G | DUTCH BROS INC BROS | CITADEL ADVISORS LLC | 4,073,886 6.5% | 865,013 (+26.96%) | View |